Cumberland Pharmaceuticals CPIX Net Operating Loss Carryforwards
Net Operating Loss Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's net operating loss carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's net operating loss carryforwards?
- Cumberland Pharmaceuticals (CPIX) reported net operating loss carryforwards of $44.1M in Q1 2026.
- How has Cumberland Pharmaceuticals's net operating loss carryforwards changed year-over-year?
- Cumberland Pharmaceuticals's net operating loss carryforwards decreased by 0.0% year-over-year, from $44.1M to $44.1M.
- What does net operating loss carryforwards mean?
- These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.